LATEST NEWS

Novavax and Catalent Announce Closing of Strategic Partnership

 GAITHERSBURG, MD, July 31, 2019: Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, and Catalent Biologics’ Paragon Gene Therapy unit, the leading viral vector development and...

MEDIA & PRESS CONTACT 

Colleen Floreck, Senior Director, Marketing and Communications

+1 443-262-3246 | cfloreck@paragonbioservices.com

JOIN THE CONVERSATION

Follow us on social media:

EVENTS

Come meet us!

BPI East

BioProcess International

September 9 – 12, 2019

Booth 202

Boston, MA

BPI East

ACG Maryland Networking

October 10, 2019

Baltimore, MD

World Vaccine Congress Washington

Cell & Gene Meeting on the Mesa

October 2 – 4, 2019

Carlsbad, CA

World Vaccine Congress Washington

Fast 50

October 17, 2019

Baltimore, MD

BPI East

Bio Innovation Conference

October 7, 2019

Bethesda, MD

ESGCT

ESGCT

October 22 – 25, 2019

Barcelona, Spain

We would be delighted to meet you in person during the show. Contact us to schedule a time to discuss your needs!